Cargando…
Raising the Barriers to Access to Medicines in the Developing World – The Relentless Push for Data Exclusivity
Since the adoption of the WTO‐TRIPS Agreement in 1994, there has been significant controversy over the impact of pharmaceutical patent protection on the access to medicines in the developing world. In addition to the market exclusivity provided by patents, the pharmaceutical industry has also sought...
Autores principales: | Diependaele, Lisa, Cockbain, Julian, Sterckx, Sigrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347964/ https://www.ncbi.nlm.nih.gov/pubmed/26818105 http://dx.doi.org/10.1111/dewb.12105 |
Ejemplares similares
-
“You hoped we would sleep walk into accepting the collection of our data”: controversies surrounding the UK care.data scheme and their wider relevance for biomedical research
por: Sterckx, Sigrid, et al.
Publicado: (2015) -
Relentless evolution /
por: Thompson, John N.
Publicado: (2013) -
Relentless Improvement
por: Trudell, Bill
Publicado: (2012) -
The relentless flu drug.
Publicado: (1998) -
The concept of justifiable healthcare and how big data can help us to achieve it
por: van Biesen, Wim, et al.
Publicado: (2021)